BD4BO organizes a Group Meeting in Stockholm from 28-30 January 2018. BD4BO (Big Data for Better Outcomes) is a comprehensive European research programme aiming to develop key enablers to support health care system transformation through the use of big data. The initiative will develop platforms for integrating and analysing diverse data sets, focusing on outcomes that matter to patients and generating meaningful insights that will help improve health care.
The HARMONY Alliance is one of the three disease-specific projects of BD4BO. Other projects are ROADMAP (Alzheimer’s Disease) and BigData@Heart. Soon a new Prostate Cancer project is to be expected.
During the BD4BO Group Meeting, HARMONY Project Coordinator Jesús María Hernández Rivas of IBSAL, and Project Co-Lead Pam Bacon, Celgene International, will present an update about the developments and milestones achieved in its first year.
Read more about BD4BO, which is funded by the Innovative Medicines Initiative (IMI2).
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
